[ARS] Viatris Inc SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

10/24/2025 - 04:19 PM

ARS - Viatris Inc

ARS Filing - Viatris Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Viatris Inc (VTRS)

Acceptance Date: 2025-10-24T16:19:02.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

#739 Ranked by Market Cap

N/A Ranked by Dividends

VTRS Latest News

Jan 20, 2026

Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure

Jan 15, 2026

Aon's Resilience Quotient Cuts Through Uncertainty and Volatility to Help Businesses Move from Risk to Resilience and Growth

Jan 8, 2026

Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer

Dec 18, 2025

Viatris Provides Pipeline Update on Four Regulatory Milestones

Dec 17, 2025

Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference

VTRS Latest SEC Filings

Nov 6, 2025

[10-Q] Viatris Inc Quarterly Earnings Report

Nov 6, 2025

[8-K] Viatris Inc Reports Material Event

Oct 24, 2025

[8-K] Viatris Inc Reports Material Event

Oct 24, 2025

[DEF 14A] Viatris Inc Definitive Proxy Statement

Sep 11, 2025

[144] Viatris Inc. SEC Filing

VTRS Stock Data

Market Cap 15.21B

Float 1.15B

Insiders Ownership 0.28%

Institutions Ownership 85.61%

Short Percent 3.48%

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website Link

Country United States

City CANONSBURG